Cancer BiologybioRxiv
MDR1 Drug Efflux Pump Promotes Intrinsic and Acquired Resistance to PROTACs in Cancer Cells
A. M. Kurimchak, C. Herrera-Montavez, S. Montserrat-Sangra…·J. S. Duncan
This study identifies MDR1 as a mediator of resistance to PROTACs in cancer cells and shows that combining MDR1 inhibitors with PROTACs enhances drug efficacy.
DOI 10.1126/scisignal.abn2707